Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational study

Lewis NM, Harker EJ, Grant LB, Zhu Y, Grijalva CG, Chappell JD, Rhoads JP, Baughman A, Casey JD, Blair PW, Jones ID, Johnson CA, Lauring AS, Gaglani M, Ghamande S, Columbus C, Steingrub JS, Shapiro NI, Duggal A, Busse LW, Felzer J, Prekker ME, Peltan ID, Brown SM, Hager DN, Gong MN, Mohamed A, Exline MC, Khan A, Hough CL, Wilson JG, Mosier J, Qadir N, Chang SY, Ginde AA, Martinez A, Mohr NM, Mallow C, Harris ES, Johnson NJ, Srinivasan V, Gibbs KW, Kwon JH, Vaughn IA, Ramesh M, Safdar B, Goyal A, DeLamielleure LE, DeCuir J, Surie D, Dawood FS, Tenforde MW, Uyeki TM, Garg S, Ellington S, Self WH; Investigating Respiratory Viruses in the Acutely Ill (IVY) Network. Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational study. Clin Infect Dis. 2024 Nov 28:ciae584. doi: 10.1093/cid/ciae584. Epub ahead of print. PMID: 39607747.


Related Posts